Inhibition of miR-21 in glioma cells using catalytic nucleic acids

Untitled work

Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works

MicroRNAs: Target Recognition and Regulatory Functions

Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works

Most mammalian mRNAs are conserved targets of microRNAs

Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462 · see citing works

Oncomirs — microRNAs with a role in cancer

Esquela‐Kerscher, A., & Slack, F. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1840 · Cited by 7,038 · see citing works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

A microRNA expression signature of human solid tumors defines cancer gene targets

Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697 · see citing works

Mammalian microRNAs predominantly act to decrease target mRNA levels

Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886 · see citing works

Widespread changes in protein synthesis induced by microRNAs

Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · see citing works

miRBase: integrating microRNA annotation and deep-sequencing data

Kozomara, A., & Griffiths-Jones, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1027 · Cited by 3,042 · see citing works

MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer

Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773 · see citing works

MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells

Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557 · see citing works

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

Kota, J., Chivukula, R. R., O’Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H., Chang, T.-C., Vivekanandan, P., Torbenson, M. S., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,711 · see citing works

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677 · see citing works

MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma

Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. �., Au, G. K. �., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,578 · see citing works

A general purpose RNA-cleaving DNA enzyme

Santoro, S. W., & Joyce, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4262 · Cited by 1,546 · see citing works

Targeting microRNAs in cancer: rationale, strategies and challenges

Garzon, R., Marcucci, G., & Croce, C. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3179 · Cited by 1,494 · see citing works

A DNA enzyme that cleaves RNA

Breaker, R. R., & Joyce, G. F. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90014-0 · Cited by 1,479 · see citing works

miR2Disease: a manually curated database for microRNA deregulation in human disease

Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., Li, M., Wang, G., & Liu, Y. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn714 · Cited by 1,415 · see citing works

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250 · see citing works

Simple RNA enzymes with new and highly specific endoribonuclease activities

Haseloff, J. P., & Gerlach, W. L. (1988) · Nature · doi:10.1038/334585a0 · Cited by 1,103 · see citing works

Specific expression of long noncoding RNAs in the mouse brain

Mercer, T. R., Dinger, M. E., Sunkin, S. M., Mehler, M. F., & Mattick, J. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706729105 · Cited by 1,103 · see citing works

Extensive modulation of a set of microRNAs in primary glioblastoma

Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096 · see citing works

Antisense technologies

Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,007 · see citing works

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

Medina, P. P., Nolde, M., & Slack, F. J. (2010) · Nature · doi:10.1038/nature09284 · Cited by 971 · see citing works

A small catalytic oligoribonucleotide

Uhlenbeck, O. C. (1987) · Nature · doi:10.1038/328596a0 · Cited by 938 · see citing works

Knocking down disease: a progress report on siRNA therapeutics

Wittrup, A., & Lieberman, J. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3978 · Cited by 810 · see citing works

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

Silber, J., Lim, D. A., Petritsch, C., Persson, A. I., Maunakea, A. K., Yu, M., Vandenberg, S. R., Ginzinger, D. G., James, C. D., Costello, J. F., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-14 · Cited by 765 · see citing works

Antisense oligonucleotides: basic concepts and mechanisms.

Dias, N., & Stein, C. A. (2002) · PubMed · Cited by 744 · see citing works

Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal

Godlewski, J. A., Nowicki, M. O., Bronisz, A., Williams, S. P., Otsuki, A., Nuovo, G. J., Ray‐Chaudhury, A., Newton, H. B., Chiocca, E. A., & Lawler, S. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2629 · Cited by 702 · see citing works

MOLECULAR PATHOLOGY OF MALIGNANT GLIOMAS

Louis, D. N. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100043 · Cited by 647 · see citing works

Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry

Berdasco, M., & Esteller, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.10.005 · Cited by 623 · see citing works

Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)

Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600 · see citing works

Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines

Gaur, A., Jewell, D. A., Liang, Y., Ridzon, D., Moore, J. H., Chen, C., Ambros, V. R., & Israel, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2698 · Cited by 593 · see citing works

Mechanism and Utility of an RNA-Cleaving DNA Enzyme

Santoro, S. W., & Joyce, G. F. (1998) · Biochemistry · doi:10.1021/bi9812221 · Cited by 454 · see citing works

Recent advances in the molecular understanding of glioblastoma

Bleeker, F. E., Molenaar, R. J., & Leenstra, S. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0793-0 · Cited by 453 · see citing works

SMALL CATALYTIC RNAs

Symons, R. H. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003233 · Cited by 452 · see citing works

Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity

Khvorova, A., Lescoute, A., Westhof, É., & Jayasena, S. D. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb959 · Cited by 440 · see citing works

Small‐Molecule Inhibitors of MicroRNA miR‐21 Function

Gumireddy, K., Young, D. D., Xiong, X., Hogenesch, J. B., Huang, Q., & Deiters, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801555 · Cited by 427 · see citing works

Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes

Takeshita, F., Patrawala, L., Osaki, M., Takahashi, R., Yamamoto, Y., Kosaka, N., Kawamata, M., Kelnar, K., Bader, A. G., Brown, D., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.207 · Cited by 420 · see citing works

MicroRNA-21 Knockdown Disrupts Glioma Growth <i>In vivo</i> and Displays Synergistic Cytotoxicity with Neural Precursor Cell–Delivered S-TRAIL in Human Gliomas

Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1045 · Cited by 406 · see citing works

The hammerhead, hairpin and VS ribozymes are catalytically proficient in monovalent cations alone

Murray, J. B., Seyhan, A. A., Walter, N. G., Burke, J. M., & Scott, W. G. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90116-8 · Cited by 374 · see citing works

Principles of microRNA regulation of a human cellular signaling network

Cui, Q., Yu, Z., Purisima, E. O., & Wang, E. (2006) · Molecular Systems Biology · doi:10.1038/msb4100089 · Cited by 368 · see citing works

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

Zhou, X., Ren, Y., Moore, L. M., Mei, M., You, Y., Xu, P., Wang, B., Wang, G., Jia, Z., Pu, P., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.126 · Cited by 358 · see citing works

Stable knockdown of microRNA in vivo by lentiviral vectors

Gentner, B., Schira, G., Giustacchini, A., Amendola, M., Brown, B. D., Ponzoni, M., & Naldini, L. (2008) · Nature Methods · doi:10.1038/nmeth.1277 · Cited by 301 · see citing works

The Role of Environmental Carcinogens, Viruses, and Genetic

Powers, A. A., & Carbone, M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.4 · Cited by 276 · see citing works

Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

Kim, H., Huang, W., Jiang, X., Pennicooke, B. H., Park, P. J., & Johnson, M. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909896107 · Cited by 239 · see citing works

Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid

Campbell, J. M., Bacon, T. A., & Wickstrom, E. (1990) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(90)90084-p · Cited by 230 · see citing works

Analysis of microRNA knockouts in mice

Park, C. Y., Choi, Y. S., & McManus, M. T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq367 · Cited by 209 · see citing works

A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma

Srinivasan, S., Patric, I. R. P., & Somasundaram, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017438 · Cited by 208 · see citing works

MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme

Li, Y., Li, W., Yang, Y., Lu, Y., He, C., Hu, G., Liu, H., Chen, J., He, J., & Yu, H. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.053 · Cited by 208 · see citing works

A specific miRNA signature in the peripheral blood of glioblastoma patients

Roth, P., Wischhusen, J., Hertler, C., Chandran, P. A., Höfer, S., Eisele, G., Weller, M., & Keller, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07307.x · Cited by 201 · see citing works

MicroRNA-21 (miR-21) Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by Targeting PTEN, RECK and Bcl-2 in Lung Squamous Carcinoma, Gejiu City, China

Xu, L.-F., Wu, Z., Chen, Y., Zhu, Q.-S., Hamidi, S., & Navab, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103698 · Cited by 194 · see citing works

Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo

Gaur, A. B., Holbeck, S. L., Colburn, N. H., & Israel, M. A. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor033 · Cited by 180 · see citing works

Protein interactions and complexes in human microRNA biogenesis and function

Perron, M. P. (2007) · Frontiers in bioscience · doi:10.2741/2865 · Cited by 167 · see citing works

MiR‐195, miR‐196b, miR‐181c, miR‐21 expression levels and O‐6‐methylguanine‐DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

Lakomý, R., Šáňa, J., Hankeová, S., Fadrus, P., Křen, L., Lžičařová, E., Svoboda, M., Doleželová, H., Smrčka, M., Vyzula, R., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02092.x · Cited by 155 · see citing works

Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases

Gavériaux‐Ruff, C., & Kieffer, B. L. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.12.003 · Cited by 146 · see citing works

Plant pathogenic RNAs and RNA catalysis

Symons, R. H. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2683 · Cited by 137 · see citing works

MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes

Lages, E., Guttin, A., Atifi, M. E., Ramus, C., Ipas, H., Dupré, I., Rolland, D. C. M., Salon, C., Godfraind, C., de Fraipont, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020600 · Cited by 133 · see citing works

Therapeutic applications of ribozymes and riboswitches

Mulhbacher, J., St-Pierre, P., & Lafontaine, D. A. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.07.002 · Cited by 130 · see citing works

Minimal sequence requirements for ribozyme activity.

McCall, M. J., Hendry, P., & Jennings, P. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5710 · Cited by 126 · see citing works

Catalytic Nucleic Acids: From Lab to Applications

Sun, L., Cairns, M. J., Saravolac, E. G., Baker, A., & Gerlach, W. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01455-8 · Cited by 121 · see citing works

Comprehensive analysis of microRNA expression profile in malignant glioma tissues

Piwecka, M., Rolle, K., Belter, A., Barciszewska, A. M., Żywicki, M., Michalak, M., Nowak, S., Naskręt-Barciszewska, M. Z., & Barciszewski, J. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.03.007 · Cited by 108 · see citing works

CRYSTALLOGRAPHIC STRUCTURES OF THE HAMMERHEAD RIBOZYME: Relationship to Ribozyme Folding and Catalysis

Wedekind, J. E., & McKay, D. B. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.475 · Cited by 105 · see citing works

Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma

Dong, H., Luo, L., Hong, S., Siu, H., Xiao, Y., Jin, L., Chen, R., & Xiong, M. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-163 · Cited by 104 · see citing works

On the origin of glioma

Jiang, Y., & Uhrbom, L. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.658976 · Cited by 100 · see citing works

Small Molecule Modifiers of the microRNA and RNA Interference Pathway

Deiters, A. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9159-3 · Cited by 99 · see citing works

MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas

Hermansen, S. K., Dahlrot, R. H., Nielsen, B. S., Hansen, S., & Kristensen, B. W. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0992-3 · Cited by 89 · see citing works

Comparative Study of DNA Enzymes and Ribozymes against the Same Full-length Messenger RNA of the Vanilloid Receptor Subtype I

Kurreck, J., Bieber, B., Jahnel, R., & Erdmann, V. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107206200 · Cited by 82 · see citing works

M i R ‐21 Modulates h TERT Through a STAT 3‐Dependent Manner on Glioblastoma Cell Growth

Wang, Y., Sun, G., Luo, H., Wang, X., Lan, F., Yue, X., Fu, L., Pu, P., Kang, C., Liu, N., et al. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00349.x · Cited by 78 · see citing works

Recent developments in the hammerhead ribozyme field

Vaish, N. K., Kore, A. R., & Eckstein, F. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.23.5237 · Cited by 78 · see citing works

Mature MiRNAs Form Secondary Structure, which Suggests Their Function beyond RISC

Belter, A., Gudanis, D., Rolle, K., Piwecka, M., Gdaniec, Z., Naskręt-Barciszewska, M. Z., & Barciszewski, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113848 · Cited by 72 · see citing works

Artificial tertiary motifs stabilize trans-cleaving hammerhead ribozymes under conditions of submillimolar divalent ions and high temperatures

Saksmerprome, V., Roychowdhury-Saha, M., Jayasena, S. D., Khvorova, A., & Burke, D. H. (2004) · RNA · doi:10.1261/rna.7159504 · Cited by 67 · see citing works

Epigenetics in human gliomas.

Kreth, S., Thon, N., & Kreth, F. (2014) · Cancer Letters · doi:10.1016/j.canlet.2012.04.008 · Cited by 65 · see citing works

Hammerhead ribozyme design and application

Amarzguioui, M., & Prydz, H. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050247 · Cited by 62 · see citing works

Designing ribozymes for the inhibition of gene expression

Bramlage, B., Luzi, E., & Eckstein, F. (1998) · Trends in biotechnology · doi:10.1016/s0167-7799(98)01236-0 · Cited by 58 · see citing works

Antagomirzymes: Oligonucleotide Enzymes That Specifically Silence MicroRNA Function

Jadhav, V., Scaria, V., & Maiti, S. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805521 · Cited by 56 · see citing works

Glioblastoma—a moving target

Westermark, B. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.676574 · Cited by 48 · see citing works

Metal Ions: Supporting Actors in the Playbook of Small Ribozymes

Johnson-Buck, A. E., McDowell, S. E., & Walter, N. G. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732512-00175 · Cited by 44 · see citing works

Biomaterials in RNAi therapeutics: quo vadis?

Wagner, E. (2013) · Biomaterials Science · doi:10.1039/c3bm60071h · Cited by 40 · see citing works

Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: Targeting secondary structures of pre-miRNA by small molecules

Murata, A., Fukuzumi, T., Umemoto, S., & Nakatani, K. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.108 · Cited by 38 · see citing works

RNA catalysis—is that it?

Wilson, T. J., & Lilley, D. M. J. (2015) · RNA · doi:10.1261/rna.049874.115 · Cited by 36 · see citing works

To Cleave or Not To Cleave: Ribozymes and Antisense

Woolf, T. M. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.227 · Cited by 25 · see citing works

A New Short Oligonucleotide-Based Strategy for the Precursor-Specific Regulation of microRNA Processing by Dicer

Kurzyńska‐Kokorniak, A., Koralewska, N., Tyczewska, A., Twardowski, T., & Figlerowicz, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077703 · Cited by 20 · see citing works

Highly Active Low Magnesium Hammerhead Ribozyme

Fedoruk‐Wyszomirska, A., Szymański, M., Wyszko, E., Barciszewska, M. Z., & Barciszewski, J. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvn182 · Cited by 18 · see citing works

The specific hydrolysis of HIV-1 TAR RNA element with the anti-TAR hammerhead ribozyme: structural and functional implications

Wyszko, E., Barciszewska, M. Z., Bald, R., Erdmann, V. A., & Barciszewski, J. (2001) · International Journal of Biological Macromolecules · doi:10.1016/s0141-8130(01)00138-6 · Cited by 13 · see citing works

Mechanism of Antisense Oligonucleotide Interaction with Natural RNAs

Serikov, R. N., Petyuk, V., Vorobijev, Y., Koval, V. V., Fedorova, O. S., Vlassov, V. V., & Аркадьевна, З. М. (2011) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/073911011010524987 · Cited by 9 · see citing works

Modulation of microRNA function by synthetic ribozymes

Suryawanshi, H., Scaria, V., & Maiti, S. (2010) · Molecular BioSystems · doi:10.1039/c0mb00010h · Cited by 7 · see citing works

Effect of high hydrostatic pressure on hydration and activity of ribozymes

Giel-Pietraszuk, M., Fedoruk‐Wyszomirska, A., & Barciszewski, J. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0024-3 · Cited by 6 · see citing works

BTECH: A Platform to Integrate Genomic, Transcriptomic and Epigenomic Alterations in Brain Tumors

Wang, M., Xie, H., Stellpflug, W., Rajaram, V., Bonaldo, M. F., Goldman, S., Tomita, T., & Soares, M. B. (2011) · Neuroinformatics · doi:10.1007/s12021-010-9091-9 · Cited by 5 · see citing works

Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21

Abels, E. R., Maas, S. L. N., Nieland, L., Wei, Z., Cheah, P. S., Tai, E., Kolsteeg, C.-J., Dusoswa, S. A., Ting, D. T., Hickman, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.036 · Cited by 199 · see citing works

MiR‐21: A key player in glioblastoma pathogenesis

Masoudi, M. S., Mehrabian, E., & Mirzaei, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26300 · Cited by 163 · see citing works

MicroRNAs in Microglia: How do MicroRNAs Affect Activation, Inflammation, Polarization of Microglia and Mediate the Interaction Between Microglia and Glioma?

Guo, Y.-W., Hong, W., Wang, X., Zhang, P., Körner, H., Tu, J., & Wei, W. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00125 · Cited by 151 · see citing works

Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma

Monfared, H., Jahangard, Y., Nikkhah, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00782 · Cited by 123 · see citing works

Triple Signal Amplification Strategy for Ultrasensitive Determination of miRNA Based on Duplex Specific Nuclease and Bridge DNA–Gold Nanoparticles

Bo, B., Zhang, T., Jiang, Y., Cui, H., & Miao, P. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05447 · Cited by 114 · see citing works

Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis

Ghaemmaghami, A. B., Mahjoubin‐Tehran, M., Movahedpour, A., Morshedi, K., Sheida, A., Taghavi, S. P., Mirzaei, H., & Hamblin, M. R. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00623-9 · Cited by 107 · see citing works

Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives

Gatto, L., Franceschi, E., Nunno, V. D., Tosoni, A., Lodi, R., & Brandes, A. A. (2021) · The Oncologist · doi:10.1002/onco.13858 · Cited by 85 · see citing works

An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas

Yan, Y., Xu, Z., Li, Z., Sun, L., & Gong, Z. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00053 · Cited by 80 · see citing works

The Therapeutic Potential of PTEN Modulation: Targeting Strategies from Gene to Protein

McLoughlin, N. M., Mueller, C., & Grossmann, T. N. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.10.009 · Cited by 73 · see citing works

The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?

Aloizou, A.-M., Pateraki, G., Siokas, V., Mentis, A.-F. A., Liampas, I., Lazopoulos, G., Kovatsi, L., Mitsias, P. D., Bogdanos, D. P., Paterakis, K., et al. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.11.001 · Cited by 69 · see citing works

Pathogenetic Features and Current Management of Glioblastoma

Nguyen, H.-M., Guz-Montgomery, K., Lowe, D. B., & Saha, D. (2021) · Cancers · doi:10.3390/cancers13040856 · Cited by 67 · see citing works

Molecular Engineering of Functional Nucleic Acid Nanomaterials toward In Vivo Applications

Zhang, J., Lan, T., & Lu, Y. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801158 · Cited by 63 · see citing works

DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics

Larcher, L. M., Pitout, I. L., Keegan, N., Veedu, R. N., & Fletcher, S. (2023) · Nucleic Acid Therapeutics · doi:10.1089/nat.2022.0066 · Cited by 48 · see citing works

RNA-Cleaving DNAzymes: Old Catalysts with New Tricks for Intracellular and In Vivo Applications

Zhang, J. (2018) · Catalysts · doi:10.3390/catal8110550 · Cited by 46 · see citing works

Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy

Wang, Y., Malik, S., Suh, H., Xiao, Y., Deng, Y., Fan, R., Huttner, A. J., Bindra, R. S., Singh, V., Saltzman, W. M., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq7459 · Cited by 45 · see citing works

Exosome-based strategies for diagnosis and therapy of glioma cancer

Fath, M. K., Azami, J., Masoudi, A., Mosaddeghi-Heris, R., Rahmani, E., Alavi, F., Bahrami, A. A., Payandeh, Z., Khalesi, B., Dadkhah, M., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02642-7 · Cited by 39 · see citing works

A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA

Kwak, G., Kim, H., Park, J., Kim, E. H., Jang, H., Han, G., Wang, S. Y., Yang, Y., Kwon, I. C., & Kim, S. H. (2021) · ACS Nano · doi:10.1021/acsnano.1c00799 · Cited by 38 · see citing works

Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer

Akhtarkhavari, T., Bahrami, A. R., & Matin, M. M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175233 · Cited by 35 · see citing works

Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers

Singh, R., Ha, S. E., Yu, T. Y., & Ro, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010415 · Cited by 34 · see citing works

The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives

Ordóñez-Rubiano, E. G., del Rincón, N. N., Espinosa, S., Shelton, W. J., Salazar, A. F., Cómbita, A. L., Baldoncini, M., Luzzi, S., Payán‐Gómez, C., Gómez-Amarillo, D. F., et al. (2024) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2024.100193 · Cited by 30 · see citing works

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

Sharma, R. K., Calderon, C., & Vivas‐Mejía, P. E. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.678593 · Cited by 28 · see citing works

Updates and current challenges in microRNA research for personalized medicine in ovarian cancer

Mandilaras, V., Vernon, M., Meryet‐Figuière, M., Karakasis, K., Lambert, B., Poulain, L., Oza, A. M., Denoyelle, C., & Lheureux, S. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1340935 · Cited by 23 · see citing works

Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells

Larcher, L. M., Wang, T., & Veedu, R. N. (2019) · Molecules · doi:10.3390/molecules24132489 · Cited by 23 · see citing works

Targeting non-coding RNA family members with artificial endonuclease XNAzymes

Donde, M. J., Rochussen, A. M., Kapoor, S., & Taylor, A. I. (2022) · Communications Biology · doi:10.1038/s42003-022-03987-5 · Cited by 21 · see citing works

Interplay of SOX transcription factors and microRNAs in the brain under physiological and pathological conditions

Stevanović, M. J., Ninković, D. S., Mojsin, M. M., Drakulić, D., & Schwirtlich, M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.338990 · Cited by 17 · see citing works

How short RNAs impact the human ribonuclease Dicer activity: putative regulatory feedback-loops and other RNA-mediated mechanisms controlling microRNA processing

Koralewska, N., Hoffmann, W., Pokornowska, M., Milewski, M. C., Lipińska, A. D., Bieńkowska-Szewczyk, K., Figlerowicz, M., & Kurzyńska‐Kokorniak, A. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1339 · Cited by 13 · see citing works

CRISPR targeting of mmu-miR-21a through a single adeno-associated virus vector prolongs survival of glioblastoma-bearing mice

Nieland, L., Vrijmoet, A. B., Jetten, I. W., Rufino‐Ramos, D., de Reus, A. J. E. M., Breyne, K., Kleinstiver, B. P., Maguire, C. A., Broekman, M. L. D., Breakefield, X. O., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.023 · Cited by 9 · see citing works

Formation of Growth‐Mediated Gold Nanoflowers: Roles of the Reducing Agent and Amine‐Modified, Single‐Strand DNA Sequences

Lone, S. A., & Sadhu, K. K. (2018) · ChemPlusChem · doi:10.1002/cplu.201800529 · Cited by 9 · see citing works

Structural variants and modifications of hammerhead ribozymes targeting influenza A virus conserved structural motifs

Czapik, T., Piasecka, J., Kierzek, R., & Kierzek, E. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.05.035 · Cited by 7 · see citing works

Expression of microRNA‑184 in glioma

Wu, X., Yang, W., Fan, G., Lin, W., Liu, F., & Lu, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7395 · Cited by 5 · see citing works

Opening new frontiers with catalytic nucleic acids in miRNA inhibition

Patutina, O., Miroshnichenko, S. K., Chiglintseva, D., & Аркадьевна, З. М. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1604711 · Cited by 3 · see citing works

Vitamin D and microRNAs

Zhao, H., Forcellati, M., Buschittari, D., Heckel, J. E., Machado, C. J., Pullagura, S. R. N., & Lisse, T. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00011-8 · Cited by 2 · see citing works

Long non-coding RNAs in glioblastoma: from molecular drivers to therapeutic targets

Elemam, N. M., Sweillam, J. H., El-Sherif, Y., Youssef, Y. A., Ismail, H. M., Assal, R. A., & Youness, R. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1887815 · Cited by 1 · see citing works

Vitamin D and MicroRNAs

Zhao, H., Pullagura, S. R. N., Rieger, S., & Lisse, T. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00015-x · Cited by 1 · see citing works

In vivo RNA targeting in the nematode Caenorhabditis elegans using exogenous catalytic DNA

Khananshvilli, E., Abraham, A.-C., Cohen, N., Staum, M., Friedman, D., & Rabinowitch, I. (2026) · BioTechniques · doi:10.1080/07366205.2026.2678313

DNA Nanoassembly Modified Polydopamine@MnO 2 Nanoparticles: Enhancement of miRNA‐21 Downregulation for Reversal of Breast Cancer Drug‐Resistance

Guo, Q., Chen, J., Wang, Y., Lv, Q., Ling, X.-Q., Song, X., & Cui, H. (2026) · Small · doi:10.1002/smll.75736

Synthetic miR-21 decoy circularized by tRNA splicing mechanism inhibited tumorigenesis in glioblastoma in vitro and in vivo models

Bayat, H., Pourgholami, M. H., Rahmani, S., Pournajaf, S., & Mowla, S. J. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.001 · Cited by 25 · see citing works

Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells

Larcher, L. M., Wang, T., & Veedu, R. N. (2019) · Molecules · doi:10.3390/molecules24132489 · Cited by 23 · see citing works

MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma

Costa, P. M., Cardoso, A. L., Nóbrega, C., Pereira de Almeida, L. F., Bruce, J. N., Canoll, P., & Pedroso de Lima, M. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds496 · Cited by 80 · see citing works

Peptide Conjugates for MicroRNA-21 Inhibition in Glioblastoma Multiforme

Chaudhry, T. (2024) · Liverpool John Moores University · doi:10.24377/ljmu.t.00019237

MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells

Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705 · see citing works